Humana to study adverse reactions

In an unprecedented initiative, the University of Miami and Humana are joining forces to study drug safety and adverse reactions. Researchers will track Humana's database of 11 million members, looking for dangerous side effects that become apparent only after a drug has been used for some time. Dubbed the Pharmacovigilance Initiative, the program is an attempt to reach beyond voluntary reporting of adverse drug reactions. Results will be reported publicly via press releases and a special website beginning in 2008.

- check out the release on the program
- here's the report on the initiative from the South Florida Business Journal

Related Articles:
Humana, University of Miami take on 'pre-sick.' Report
Pharmacovigilance grows in importance. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.